Diabetic urethropathy compounds the effects of diabetic cystopathy

J Urol. 2007 Nov;178(5):2213-9. doi: 10.1016/j.juro.2007.06.042. Epub 2007 Sep 17.

Abstract

Purpose: The effects of short-term and long-term diabetes mellitus on urethral function were investigated to determine the contribution of urethral dysfunction to diabetes mellitus voiding dysfunction.

Materials and methods: Isovolumetric bladder pressure, urethral perfusion pressure and external urethral sphincter electromyography were measured in urethane anesthetized, female Sprague-Dawley rats (Charles River Laboratories, Wilmington, Massachusetts) 5 or 10 weeks after streptozotocin induced diabetes mellitus. Urethral responses to serial administration of the skeletal muscle blocker alpha-bungarotoxin, the nitric oxide synthase inhibitor N(omega)-nitro-L-arginine and the alpha-adrenergic agonist L-phenylephrine were determined in diabetes mellitus and age matched controls.

Results: Peak bladder pressures and contraction amplitudes were significantly decreased in diabetes mellitus rats. Detrusor-sphincter dyssynergia occurred in approximately 30% of diabetes mellitus rats but never in controls. Alpha-Bungarotoxin caused a greater decrease in baseline urethral perfusion pressure in diabetes mellitus rats than in controls (approximately 40% vs approximately 15%). Bladder contraction associated urethral smooth muscle relaxation amplitudes were significantly less in diabetes mellitus rats than in controls. N(omega)-nitro-L-arginine significantly suppressed urethral relaxation in controls but not in diabetes mellitus rats. L-phenylephrine significantly increased baseline urethral perfusion pressure in diabetes mellitus rats but not in controls. The unassociated conditions of insensitivity to N-nitro-L-arginine and hypersensitivity to L-phenylephrine were more common in 10-week diabetes mellitus rats than in control rats.

Conclusions: Diabetes mellitus induced urethropathy is characterized by external urethral sphincter dysfunction, decreased urethral smooth muscle relaxation and nitric oxide responsiveness, and increased urethral smooth muscle responsiveness to alpha(1)-adrenergic agonists. These changes increase outlet resistance and, thereby, decrease voiding efficiency. This exacerbates voiding dysfunction, creating a vicious cycle of progressive lower urinary tract damage and dysfunction. Early intervention targeting outlet resistance may be indicated.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adrenergic alpha-Agonists / administration & dosage
  • Animals
  • Antibiotics, Antineoplastic / toxicity
  • Arginine / administration & dosage
  • Arginine / analogs & derivatives
  • Bungarotoxins / administration & dosage
  • Diabetes Mellitus, Experimental / complications*
  • Diabetes Mellitus, Experimental / physiopathology
  • Electromyography
  • Female
  • Follow-Up Studies
  • Muscle Contraction / physiology
  • Phenylephrine / administration & dosage
  • Rats
  • Rats, Sprague-Dawley
  • Streptozocin / toxicity
  • Urethra / physiopathology*
  • Urethral Diseases / drug therapy
  • Urethral Diseases / etiology*
  • Urethral Diseases / physiopathology
  • Urinary Bladder / physiopathology*
  • Urinary Bladder Diseases / drug therapy
  • Urinary Bladder Diseases / etiology*
  • Urinary Bladder Diseases / physiopathology

Substances

  • Adrenergic alpha-Agonists
  • Antibiotics, Antineoplastic
  • Bungarotoxins
  • Phenylephrine
  • N(omega)-hydroxyarginine
  • Streptozocin
  • Arginine